Terrence C. Kearney, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 68,125 shares at $127.50 ($8.8M) on 2015-04-27, disclosed to the SEC on 2015-04-29.
Scheduled sale ($8.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $127.50 | 26,593 | $3.4M | 38.6% |
| 2 | $128.12 | 16,295 | $2.1M | 23.7% |
| 3 | $129.94 | 4,500 | $585K | 6.6% |
| 4 | $130.58 | 8,800 | $1.1M | 13.1% |
| 5 | $131.76 | 3,969 | $523K | 5.9% |
| 6 | $132.82 | 5,668 |
| $753K |
| 8.6% |
| 7 | $133.63 | 2,300 | $307K | 3.5% |
| Total | $129.11 avg | 68,125 | $8.8M | 100% |
| Filing → |
| VRTX | SELL | 2019-11-04 | $6.5M | — | Filing → |
| HSP | SELL | 2010-12-17 | $10.3M | — | Filing → |
| HSP | SELL | 2010-10-25 | $1.7M | — | Filing → |